🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase 1b Study RDX-002-22-09 has been planned to evaluate the effect o...
Status
Completed
Location
Nucleus Network
Start Date
2023-05-16
Trial ID
NCT05857566
Treatments Being Tested
The purpose of this study is to determine whether melatonin can prevent met...
Status
Completed
Location
Shafa Psychiatric Hospital
Start Date
2012-05
Trial ID
NCT01593774
The purpose of this 6 month study is to compare the metabolic effects of pa...
Status
Completed
Location
Multiple Locations
Start Date
2007-10
Trial ID
NCT00645099
Treatments Being Tested
The purpose of this research study is to see if olanzapine helps to prevent...
Status
Completed
Location
UNC Hospital
Start Date
2020-08-18
Trial ID
NCT04535141
Treatments Being Tested
Fute (Flupentixol) combined with MARTAs (Multiple-Acting Receptor Targeted ...
Status
Completed
Location
Taichung Veterans General Hospital
Start Date
2019-12-19
Trial ID
NCT04898270
Treatments Being Tested
The purpose of this study is to gather information about the steady-state p...
Status
Completed
Location
Multiple Locations
Start Date
2014-02
Trial ID
NCT02087579
Nausea and vomiting (PONV) remain a common problem in surgical units. Even ...
Status
Completed
Location
Assiut university hospitals
Start Date
2021-03-15
Trial ID
NCT04718727
Treatments Being Tested
A Clinical Study that will look at an investigational medication, SEP-36385...
Status
Completed
Location
Woodland International Research Group
Start Date
2022-11-15
Trial ID
NCT05542264
Treatments Being Tested
This is a 12-week study which investigates the use of olanzapine to decreas...
Status
Completed
Location
Drexel University College of Medicine c/o Friends Hospital
Start Date
2003-05
Trial ID
NCT00057408
Treatments Being Tested
The primary objective of this phase 2 randomized controlled trial is to det...
Status
Completed
Location
Yale New Haven Hospital
Start Date
2023-06-26
Trial ID
NCT05676294
Treatments Being Tested